Healthy Immigrant Community: Mobilizing the Power of Social Networks

April 26, 2024 updated by: Mark L Wieland, Mayo Clinic
The objective of this study is to leverage existing social networks for health behavior change relevant to obesity and cardiovascular risk among immigrant populations in Southeast, Minnesota.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Actual)

481

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Self-identification as Hispanic or Somali.
  • Member of a social network identified in the social network analysis.
  • Willingness to participate in all aspects of the study.
  • Provision of informed consent.

Exclusion Criteria:

  • Pregnancy at the time of enrollment.
  • Serious medical conditions or disabilities that would make physical activity difficult.
  • To avoid stigmatization, a normal weight (BMI<25) will not exclude individuals from participating in the intervention, but they will be excluded from the measurements and analyses.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Immediate Community-Based Mentoring and Education Sessions
Subjects will receive the intervention of community-based mentoring and education sessions immediately after enrollment.
Community-based mentoring and education sessions, group activities, and application of a community toolkit for healthy weight loss delivered by trained Health Promoters from Hispanic and Somali communities to their social networks.
Experimental: Delayed Community-Based Mentoring and Education Sessions
Subjects will receive the intervention of community-based mentoring and education sessions approximately 12 months after enrollment.
Community-based mentoring and education sessions, group activities, and application of a community toolkit for healthy weight loss delivered by trained Health Promoters from Hispanic and Somali communities to their social networks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body Mass Index (BMI)
Time Frame: Baseline, 6 months, 12 months, 24 months
BMI is calculated as weight (kg)/height squared (m2)
Baseline, 6 months, 12 months, 24 months
Change in waist circumference
Time Frame: Baseline, 6 months, 12 months, 24 months
Measured to the nearest 0.1 cm at the narrowest part of the torso between the ribs and the iliac crest.
Baseline, 6 months, 12 months, 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in "Life's Simple 7" Composite Score
Time Frame: Baseline, 6 months, 12 months, 24 months
Adapted from the American Heart Association standards based on health assessment data. Point values are assigned to each component: 2 points for ideal, 1 point for intermediate, 0 points for poor. The total sum allows for a continuous measure of cardiovascular health ranging from poor to ideal (0-14 points). The final score will be categorized as 0-6 (poor), 7-8 (intermediate), 9-14 (ideal).
Baseline, 6 months, 12 months, 24 months
Change in blood pressure (systolic and diastolic)
Time Frame: Baseline, 6 months, 12 months, 24 months
Measured three times and the average of the second and third readings will be used in analyses, reported in mmHg.
Baseline, 6 months, 12 months, 24 months
Change in fasting glucose level
Time Frame: Baseline, 6 months, 12 months, 24 months
6 hours fasting glucose blood serum level, reported in mg/dL
Baseline, 6 months, 12 months, 24 months
Change in low-density lipoprotein (LDL)
Time Frame: Baseline, 6 months, 12 months, 24 months
Change in LDL cholesterol blood serum level, reported in mg/dL
Baseline, 6 months, 12 months, 24 months
Change in Dietary Quality
Time Frame: Baseline, 6 months, 12 months, 24 months
24-hour dietary recall collected using the Nutrition Data System for Research (NDSR) used to calculate the Healthy Eating index (HEI-2015), scores categorized as HEI≥69.3 optimal, HEI 56.9-69.2 intermediate, HEI<56.9 poor
Baseline, 6 months, 12 months, 24 months
Change in physical activity
Time Frame: Baseline, 6 months, 12 months, 24 months
Measured using the International Physical Activity Questionnaire (IPAQ) that assesses the number of minutes of mild, moderate, and vigorous physical activity over the previous 7 days, scores categorized as ≥150 min/wk moderate or ≥75 min/wk vigorous or ≥150 min/wk moderate+vigorous = optimal; 1-149 min/wk moderate or 1-74 min/wk vigorous or 1-149 min/wk moderate+vigorous = intermediate; no physical activity = poor
Baseline, 6 months, 12 months, 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Mark Wieland, MD, Mayo Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 23, 2022

Primary Completion (Estimated)

July 30, 2024

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

November 16, 2021

First Submitted That Met QC Criteria

November 16, 2021

First Posted (Actual)

November 29, 2021

Study Record Updates

Last Update Posted (Actual)

April 29, 2024

Last Update Submitted That Met QC Criteria

April 26, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 21-009339
  • P50MD017342-01 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Weight Loss

Clinical Trials on Community-based mentoring and education sessions

3
Subscribe